Innoviva (INVA) Capital Expenditures (QoQ) (2010 - 2022)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Innoviva | 1.60 Bn | 992.84 Mn | 75.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 153.85% |
| Jun 30, 2022 | 44.44% |
| Mar 31, 2020 | 8.33% |
| Dec 31, 2016 | -88.43% |
| Sep 30, 2016 | 2,925.00% |
| Mar 31, 2015 | -95.49% |
| Jun 30, 2014 | -165.68% |
| Mar 31, 2014 | 51.83% |
| Dec 31, 2013 | 352.12% |
| Sep 30, 2013 | -65.85% |
| Jun 30, 2013 | -6.62% |
| Mar 31, 2013 | 183.52% |
| Dec 31, 2012 | -53.97% |
| Sep 30, 2012 | -13.96% |
| Jun 30, 2012 | -40.25% |
| Mar 31, 2012 | 21.88% |
| Dec 31, 2011 | 2,362.50% |
| Sep 30, 2011 | -102.89% |
| Jun 30, 2011 | 0.07% |
| Mar 31, 2011 | 140.17% |
| Dec 31, 2010 | 275.82% |